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http://dx.doi.org/10.1016/j.devcel.2012.09.017We have previously identified SATB1 as a
silencing factor for Xist in T cell tumors
and suggested a contribution to X
inactivation in mice (Agrelo et al., 2009).
Nechanitzky et al. (2012) present new
data in this issue of Developmental Cell
that suggest that additional factors are
involved in the initiation of X chromosome
inactivation (XCI). The manuscript ex-
tends a previous study of the function of
SATB1 and SATB2 in embryonic stem
(ES) cells (Savarese et al., 2009) and pres-
ents new data from mice. The conclusion
is that embryos of both sexes can be ob-
tained in the absence of Satb1 and Satb2,
consistent with the idea that XCI is not
impaired in Satb1/Satb2/ mice. This
finding strongly suggests that Satb1 and
Satb2 are not critical for XCI in mouse
development.
The data on the survival of Satb1 and
Satb2 double-deficient ES cells (Savarese
et al., 2009) are in apparent conflict with
our previous observation that combined
loss of Satb1 and Satb2 is not compatible
with ES cell maintenance (Agrelo et al.,
2009). In our study, we have carried out
RNA interference (RNAi) experiments
that indicated that combined application
of Satb1 and Satb2 siRNAs was not toler-
ated by ES cells. This could be explained
by potential off-target effects in our RNAi
experiments, which we cannot fully rule
out. However, we point out that our exper-
iments have shown a robust effect of
Satb1 and Satb2 double RNAi with more
than one siRNA sequence, whereas indi-
vidual application and the same siRNAs
did not compromise ES cells. Our results
could suggest that ES cells are sensitive
to an acute loss of Satb1 and Satb2. In
contrast, when ES cells are derived from
Satb1/Satb2/ embryos, compensa-
tion by other factors could facilitate ES680 Developmental Cell 23, October 16, 2012cell line derivation. This idea is further
consistent with the fact that Satb2-defi-
cient ES cells cannot be derived, whereas
Satb1 and Satb2 double-deficient ES
cells have been derived in the expected
frequency (Savarese et al., 2009).
Using an ES cell line that enabled
examination of gene silencing following
Xist induction, we have observed that
SATB1 protein expression overlaps with
the ability of Xist to induce gene repres-
sion in ES cell differentiation (Agrelo
et al., 2009). Nechanitzky et al. (2012)
and Savarese et al. (2009) come to
different conclusions that are partly in
conflict with our results. Although some
of these data are hard to reconcile with
our observations, all studies agree that
SATB1 is expressed in ES cells. Some
discrepancies might be due to the use of
different ES cell lines, antibodies, differen-
tiation conditions, or standardization.
Whereas we used actin or the nuclear
protein Lamin B to control for loading, Sa-
varese et al. and Nechanitzky et al. used
the metabolic gene GAPDH, whose
expression could potentially be affected
by differentiation. Nechanitzky et al. also
examine SATB1 expression in thymo-
cytes. In agreement with a recent report,
they observe expression in a subset of
single positive T cells (Beyer et al.,
2011). We have suggested that Xist-medi-
ated silencing is restricted in T cell differ-
entiation and have seen the greatest
effect in the CD4+ CD8+ double-positive
compartment (Savarese et al., 2006).
However, our data also showed that
single-positive T cells are reduced after
Xist induction. Because single-positive
T cells are derived from the double-posi-
tive compartment, loss of upstream
progenitors could potentially explain this
reduction, thus our careful interpretationª2012 Elsevier Inc.of Xist function in single-positive T cells
in the original study (Savarese et al.,
2006). In addition, some of the Xist
responsive tumors were also character-
ized as single positive (Agrelo et al.,
2009). We therefore do not believe that
the expression data by Nechanitzky
et al. are in conflict with our earlier report
and can be resolved by the actual exper-
imental data. Rapid loss of SATB1-
expressing thymocytes after Xist induc-
tion further supports the idea that
SATB1 expression correlates with silenc-
ing potential of Xist in thymocytes (Agrelo
et al., 2009).
In conclusion, we believe that our idea
of a role of SATB1 and related factors in
X inactivation is well supported. The new
data by Nechanitzky et al. point to the
involvement of additional factors other
than SATB1 and SATB2, a possibility we
have also considered in our paper (Agrelo
et al., 2009).REFERENCES
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